scorecardresearch
Thursday, July 24, 2025
TopicRemdesivir

Topic: Remdesivir

Rs 60,000 for a Rs 5,500 vial — how remdesivir black-market thrives as Covid cases rise

It is alleged that the racket is operating through hospital staff who have access to remdesivir. Modi govt, states have initiated steps to check black-marketing.

Govt steps up pressure on remdesivir-makers to increase output, crack down on black marketing

Pharma firms have asked govt for a forecast on Covid trajectory to meet demand since manufacturing remdesivir takes time, by which time a vaccine could become available.

Glenmark’s favipiravir under govt scanner for ‘false claims’, cost, DCGI seeks clarification

Complaint by MP to DCGI  also highlights that the cost proposed by Glenmark is ‘definitely not in the interest of the poor, lower middle class and middle-class people of India’.

Parliamentary panel flags black-marketing of remdesivir, govt says ‘taking action’

The standing committee on home affairs met Wednesday during which members also suggested revisiting the archaic Epidemic Disease Act, 1897.

Gilead data shows remdesivir reduces mortality risk by 62% among Covid patients

Pharma company Gilead says the findings, though important, still need to be confirmed through further clinical trials.

Coronavirus could become resistant to Covid drug remdesivir, study says

Conducted by researchers in India and Japan, the study is yet to be peer-reviewed. Experts have urged caution in interpreting its findings.

India could be producing over 20,000 vials of Remdesivir per day by month-end: Govt data

Remdesivir is now being manufactured by Cipla, Hetero Labs and Mylan. Cipla Wednesday launched the drug under the brand name Cipremi.

After complaint, Modi govt asks states to keep vigil to stop ‘black-marketing’ of remdesivir

The order comes after the govt received a complaint from LocalCircles, saying the drug, whose MRP is Rs 5,400, is being sold at a price of between Rs 15,000 and Rs 60,000. 

Remdesivir to HCQ: What works against Covid-19, and what doesn’t

A physician and scientist writes about the drugs and treatments that have worked against the coronavirus, and busts some myths.

Govt ‘reviewing’ remdesivir use for Covid after hospitals report liver damage in patients

Remdesivir, allowed for use among Covid patients in India as an ‘investigational therapy’, is not advised for those with signs of liver damage.

On Camera

Defence, tech, education—Modi’s visit will boost India-UK ties

Given the immediate challenges on India’s borders, cooperation in the defence sector with partners such as the UK has achieved greater importance.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Indian firm sets up titanium, superalloy plants to meet global need. Safran, Dassault, BAE line up

PTC Industries is investing Rs 1,000 cr in 4 manufacturing plants in UP, has already started supplying titanium parts to BAE Systems for its M-777 howitzers that India also uses.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.